Victoza (liraglutide, diabetes label)
Daily liraglutide for type 2 diabetes — the same molecule as Saxenda at lower doses. No cash price published.
- Medication
- brand
- Form
- injection
- Price checked
- 2026-09-10
RxNorm 897123 for the product, 475968 for the ingredient. The codes the US National Library of Medicine assigns, so this page names one specific thing rather than a brand that could mean several.
It carries a boxed warning — the strongest the FDA issues
In both sexes of rats and mice this molecule caused thyroid C-cell tumors at clinically relevant exposures. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.
From FDA prescribing information for VICTOZA. Everything the label lists, including who cannot take it →
Read from NovoCare on 10 September 2026: Novo publishes no self-pay price for Victoza. Its product page and its page for people without insurance list Victoza and send you to a coverage checker rather than a figure. Generic liraglutide exists and is priced separately by the pharmacies dispensing it.
What this page used to say
- 2026-09-13 — Removed: how liraglutide compared with weekly semaglutide and dulaglutide in trials. Was: Seven injections a week. Head to head, weekly semaglutide 1 mg lowered HbA1c and weight more than daily liraglutide 1.2 mg in SUSTAIN 10, but weekly dulaglutide 1.5 mg only matched liraglutide 1.8 mg on HbA1c in AWARD-6. It is here because it is still prescribed and still asked about. Now: Seven injections a week. It is here because it is still prescribed and still asked about.
- 2026-09-12 — How liraglutide compares with the weekly drugs. Was: Seven injections a week for a molecule the newer weekly drugs beat on every trial figure. It is here because it is still prescribed and still asked about. Now: Seven injections a week. Head to head, weekly semaglutide 1 mg lowered HbA1c and weight more than daily liraglutide 1.2 mg in SUSTAIN 10, but weekly dulaglutide 1.5 mg only matched liraglutide 1.8 mg on HbA1c in AWARD-6. It is here because it is still prescribed and still asked about.
- 2026-09-11 — The date the label was published. Was: label published 2025-11-16. Now: label published 2025-11-17.
- 2026-09-08 — The date the label was published, and the order of the serious reactions. Was: label published 2025-10-14. Now: label published 2025-11-16.
- 2026-09-05 — Rebuilt the serious reactions as the label's section 5, in the label's order. Was: Five items: acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, pulmonary aspiration. Now: Seven, in label order: acute pancreatitis (5.2), hypoglycemia (5.4), acute kidney injury (5.5), severe gastrointestinal reactions (5.6), hypersensitivity reactions (5.7), acute gallbladder disease (5.8), pulmonary aspiration under anesthesia (5.9).
- 2026-09-05 — Added the label warning against sharing a pen between patients. Was: The serious reactions list did not mention pen sharing. Now: Never share a pen between patients, even with a new needle (5.3) — sharing risks passing on blood-borne infection.
How much does Victoza (liraglutide, diabetes label) cost a month?
halfrx records no verified price for Victoza (liraglutide, diabetes label): nothing it publishes states an all-in monthly figure, so this medication carries no price here rather than a guess. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. It carries one flag on this site: boxed warning. It scores 3.0 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. The medication is the branded, FDA-approved product rather than a compounded copy. The page rests on 2 cited sources, at least one of them a manufacturer, regulator or journal. Anything past 45 days without a re-check is marked stale here rather than quietly aging. Molecule: liraglutide.
No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price
What is good about Victoza?
What are the downsides of Victoza?
- −Novo publishes no cash price and its page routes to a coverage checker instead of a figure.[1]
- −Daily injection rather than weekly, and at doses below the 3 mg the weight-loss trials used.[1]
- −Weight loss is off-label here; the percentages quoted for liraglutide come from Saxenda's trials at a higher dose.[1]
How this score is built
- 0.0/3.5Evidence — no weight-management trial figure recorded
- 3.0/3Approval — FDA approved for type 2 diabetes and cardiovascular risk reduction. Weight loss is off-label use.
- 0.0/2.5Cost — no verified price
- 0.0/1Caveats — −1.4: off-label for weight −0.4, weaker molecule −0.5, boxed warning −0.5
Clinical evidence
FDA approved for type 2 diabetes and cardiovascular risk reduction. Weight loss is off-label use.
LEAD and LEADER trials in type 2 diabetes. The weight-loss figures quoted for liraglutide come from the SCALE trials, which were run at the higher 3 mg dose sold as Saxenda rather than at Victoza's doses.
How long Victoza takes to work, and what each week costs →
What you can take instead of Victoza, with each one's verified price →
What Victoza costs with insurance
There is no single figure, and any page giving one is describing a plan that is not necessarily yours. What decides it is below, and every part of it is checkable.
- The indication on the prescription. A plan that excludes weight-loss drugs excludes the use, not the molecule — and Victoza is separately approved for glycemic control in type 2 diabetes, which that exclusion does not reach. What each drug is approved to treat.
- If the answer is no. The cash price is what remains, and it is on this page. Every verified route to the same drug is priced with the date each was read.
What Victoza costs without insurance, and every route to the same drug →
What the label says goes wrong, and who cannot take it →
Maintenance dose 1.2 mg or 1.8 mg once daily, reachable no earlier than week 2. The full schedule, and what each step costs →
Sources
- [1] Victoza product page, NovoCareprimary
- [2] FDA prescribing information for VICTOZAprimary
Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.
Everything on Victoza
- Victoza price and terms →
- Victoza cost without insurance →
- Alternatives to Victoza →
- Victoza side effects →
- Does Victoza make you feel sick? →
- Does Victoza cause constipation? →
- Does Victoza cause diarrhea? →
- Does Victoza make you throw up? →
- Does Victoza cause indigestion? →
- Does Victoza take away your appetite? →
- Victoza dose schedule →
- How to inject Victoza →
- How long Victoza takes to work →
- Which labels record what happens when you stop →
- Hair loss: which of the labels name it →
- Alcohol: what the labels say, and what they do not →
- liraglutide: every product and price →
- Hone Health: the seller →
- Saxenda: the drug →